Direct Inhibition of β-catenin: A new strategy for colorectal cancer
Oncoscience
.
2019 Jan 31;6(1-2):294-295.
doi: 10.18632/oncoscience.477.
eCollection 2019 Jan.
Authors
Shanthi Ganesh
1
,
Bob D Brown
1
,
Marc Abrams
1
Affiliation
1
Dicerna Pharmaceuticals, Inc, Cambridge, MA 02140, USA.
PMID:
30800717
PMCID:
PMC6382254
DOI:
10.18632/oncoscience.477
No abstract available
Keywords:
Colorectal Cancer; Combinations; RNAi therapeutics; Resistance; Wnt/β-catenin pathway.